American Heart Journal

1

Cardiac conduction system disease after transcatheter aortic valve replacement

Benjamin A. Steinberg, J. Kevin Harrison, Camille Frazier-Mills, G. Chad Hughes, Jonathan P. Piccini

Journal:

Year:

2012

Language:

english

File:

PDF, 666 KB

english, 2012

2

Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction

Ingo Eitel, Volker Adams, Patrick Dieterich, Georg Fuernau, Suzanne de Waha, Steffen Desch, Gerhard Schuler, Holger Thiele

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 532 KB

english, 2012

3

Modulating peroxisome proliferator–activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects

Robert S. Rosenson, R. Scott Wright, Michael Farkouh, Jorge Plutzky

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 198 KB

english, 2012

4

Editorial Board

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 127 KB

english, 2012

6

Information for Readers

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 112 KB

english, 2012

7

Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery

Camilla Lund Søraas, Charlotte Friis, Kristin Victoria Tunheim Engebretsen, Leiv Sandvik, Sverre Erik Kjeldsen, Theis Tønnessen

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 313 KB

english, 2012

8

Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

Søren Lindberg, Sune H. Pedersen, Rasmus Mogelvang, Søren Galatius, Allan Flyvbjerg, Jan Skov Jensen, Mette Bjerre

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 239 KB

english, 2012

9

Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: An analysis from ACT34-CMI

Thomas J. Povsic, Douglas W. Losordo, Kenneth Story, Candice E. Junge, Richard A. Schatz, Robert A. Harrington, Timothy D. Henry

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 653 KB

english, 2012

10

De Facto regionalization of care for ST-elevation myocardial infarction in Florida, 2001–2009

Colin J. Forsyth, Elizabeth Barnett Pathak, Joel A. Strom

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 509 KB

english, 2012

11

Clarification of the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment (REMIT) Trial Protocol

Brett D. Thombs

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 56 KB

english, 2012

12

Response to the “Clarification of the REMIT Trial Protocol”

Wei Jiang, Maragatha Kuchibhatla, Christopher O'Connor

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 47 KB

english, 2012

13

Randomized controlled trial of ventricular elastic support therapy in the treatment of symptomatic heart failure: Rationale and design

William T. Abraham, Inder Anand, Juan M. Aranda Jr., John Boehmer, Maria Rosa Costanzo, Teresa DeMarco, Richard Holcomb, Russell Ivanhoe, Michael Kolber, Barry Rayburn

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 556 KB

english, 2012

14

Prognostic implications of troponin T and creatine kinase–MB elevation after coronary artery bypass grafting

Michael J. Domanski

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 69 KB

english, 2012

15

Randomized controlled trial comparing simultaneous versus optimized sequential interventricular stimulation during cardiac resynchronization therapy

William T. Abraham, Angel R. León, Martin G. St. John Sutton, Steven J. Keteyian, Ann M. Fieberg, Ed Chinchoy, Garrie Haas

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 505 KB

english, 2012

16

The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction

Suzan Willemsen, Jasper W.L. Hartog, Dirk J. van Veldhuisen, Peter van der Meer, Joline F. Roze, Tiny Jaarsma, Casper Schalkwijk, Iwan C.C. van der Horst, Hans L. Hillege, Adriaan A. Voors

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 495 KB

english, 2012

17

The Study Of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): Design and rationale

Chiara Melloni, Dennis L. Sprecher, Lea Sarov-Blat, Manesh R. Patel, John F. Heitner, Christian W. Hamm, Philip Aylward, Jean-Francois Tanguay, Robbert J. DeWinter, Michael S. Marber, Amir Lerman, Vic

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 337 KB

english, 2012

18

Erythropoietin treatment in patients with acute myocardial infarction: A meta-analysis of randomized controlled trials

Dengfeng Gao, Ning Ning, Xiaolin Niu, Yinhu Dang, Xin Dong, Jin Wei, Canzhan Zhu

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 1.81 MB

english, 2012

19

Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications

Brett D. Atwater, David Dai, Nancy M. Allen-Lapointe, Sana M. Al-Khatib, Louise O. Zimmer, Gillian D. Sanders, Eric D. Peterson

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 123 KB

english, 2012

20

Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department

Jeanette Normann, Matthias Mueller, Moritz Biener, Mehrshad Vafaie, Hugo A. Katus, Evangelos Giannitsis

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 498 KB

english, 2012

21

Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: An intra-patient comparison

Sander F. Rodrigo, Jan van Ramshorst, Saskia L. Beeres, Imad Al Younis, Petra Dibbets-Schneider, Albert de Roos, Willem E. Fibbe, Jaap J. Zwaginga, Martin J. Schalij, Jeroen J. Bax, Douwe E. Atsma

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 479 KB

english, 2012

22

Comprehensive geriatric assessment and hospital mortality among older adults with decompensated heart failure

Carlos Rodríguez-Pascual, Arturo Vilches-Moraga, Emilio Paredes-Galán, Ana Isabel Ferrero-Marinez, Marta Torrente-Carballido, Fernando Rodríguez-Artalejo

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 135 KB

english, 2012

23

ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design

Roberto Diletti, Patrick W. Serruys, Vasim Farooq, Krishnankutty Sudhir, Cecile Dorange, Karine Miquel-Hebert, Susan Veldhof, Richard Rapoza, Yoshinobu Onuma, Hector M. Garcia-Garcia, Bernard Chevalie

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 419 KB

english, 2012

24

Regionalization of ST-segment elevation myocardial infarction care: A task unfinished

Akshay Bagai, Christopher B. Granger

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 90 KB

english, 2012

25

Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction

Kalkidan Bishu, Anita Deswal, Horng H. Chen, Martin M. LeWinter, Gregory D. Lewis, Marc J. Semigran, Barry A. Borlaug, Steven McNulty, Adrian F. Hernandez, Eugene Braunwald, Margaret M. Redfield

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 207 KB

english, 2012

26

Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study

Anju Bhardwaj, Shafiq U. Rehman, Asim A. Mohammed, Hanna K. Gaggin, Linda Barajas, Justine Barajas, Stephanie A. Moore, Dorothy Sullivan, James L. Januzzi

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 326 KB

english, 2012

27

Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients—Results from the PLATelet inhibition and patient Outcomes (PLATO) study

Axel Åkerblom, Lars Wallentin, Agneta Siegbahn, Richard C. Becker, Andrzej Budaj, Jay Horrow, Steen Husted, Hugo Katus, Marc J. Claeys, Robert F. Storey, Nils Åsenblad, Stefan K. James

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 152 KB

english, 2012

Volume 164; Issue 5

Cardiac conduction system disease after transcatheter aortic valve replacement

Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction

Modulating peroxisome proliferator–activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects

Table of Contents

Editorial Board

Information for Readers

Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery

Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: An analysis from ACT34-CMI

De Facto regionalization of care for ST-elevation myocardial infarction in Florida, 2001–2009

Clarification of the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment (REMIT) Trial Protocol

Response to the “Clarification of the REMIT Trial Protocol”

Randomized controlled trial of ventricular elastic support therapy in the treatment of symptomatic heart failure: Rationale and design

Prognostic implications of troponin T and creatine kinase–MB elevation after coronary artery bypass grafting

Randomized controlled trial comparing simultaneous versus optimized sequential interventricular stimulation during cardiac resynchronization therapy

The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction

The Study Of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): Design and rationale

Erythropoietin treatment in patients with acute myocardial infarction: A meta-analysis of randomized controlled trials

Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications

Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department

Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: An intra-patient comparison

Comprehensive geriatric assessment and hospital mortality among older adults with decompensated heart failure

Regionalization of ST-segment elevation myocardial infarction care: A task unfinished

Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction

Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study

Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients—Results from the PLATelet inhibition and patient Outcomes (PLATO) study